An internal standard for the quantification of clofibric acid
Related Products
Unlabeled Version(s)
21608Clofibric Acid
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Clofibric Acid-d4

Item No. 33612

Technical Information
Formal Name
2-(4-chlorophenoxy-d4)-2-methyl-propanoic acid
CAS Number
1184991-14-7
Molecular Formula
C10H7ClD4O3
Formula Weight
Purity
≥99% deuterated forms (d1-d4)
Formulation
A solid
Acetonitrile: solubleDMSO: solubleMethanol: soluble
SMILES
OC(C(C)(C)OC1=C([2H])C([2H])=C(C([2H])=C1[2H])Cl)=O
InChi Code
InChI=1S/C10H11ClO3/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6H,1-2H3,(H,12,13)/i3D,4D,5D,6D
InChi Key
TXCGAZHTZHNUAI-LNFUJOGGSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Clofibric acid-d4 is intended for use as an internal standard for the quantification of clofibric acid (Item No. 21608) by GC- or LC-MS. Clofibric acid is a peroxisome proliferator-activated receptor α (PPARα) agonist (EC50 = 50 µM in a transactivation assay) and the active metabolite of clofibrate (Item No. 10956).1 It is formed from clofibrate by tissue and serum esterases.2 Dietary administration of clofibric acid (0.067-0.22%) reduces serum cholesterol, phospholipid, and triglyceride levels in rats.3 It decreases glutamate oxaloacetate transaminase (GOT) levels and increases glutamate pyruvate transaminase (GPT) and lactate dehydrogenase (LDH) levels, markers of xenobiotic stress, in the plasma of carp (C. carpio) when administered in tank water at a concentration of 10 µg/L.4 Clofibric acid has been found in wastewater effluent.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Giampietro, L., Laghezza, A., Cerchia, C., et alNovel phenyldiazenyl fibrate analogues as PPAR α/γ/δ pan-agonists for the amelioration of metabolic syndrome. ACS Med. Chem. Lett. 10(4), 545-551 (2019).

    2. Cayen, M.N. Metabolic disposition of clofibrate. Drug Metabol. Drug Interact. 3(1 & 2), 77-103 (1980).

    3. Cayen, M.N., Ferdinandi, E.S., Greselin, E., et alClofibrate and clofibric acid: Comparison of the metabolic disposition in rats and dogs. J. Pharmacol. Exp. Ther. 200(1), 33-43 (1977).

    4. Saravanan, M., Karthika, S., Malarvizhi, A., et alEcotoxicological impacts of clofibric acid and diclofenac in common carp (Cyprinus carpio) fingerlings: Hematological, biochemical, ionoregulatory and enzymological responses. J. Hazard. Mater. 195, 188-194 (2011).

    5. Tixier, C., Singer, H.P., Oellers, S., et alOccurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 37(6), 1061-1068 (2003).